Allurion Technologies Inc. (ALUR)
- Previous Close
1.8500 - Open
1.8900 - Bid 1.9200 x 1100
- Ask 2.1100 x 800
- Day's Range
1.8600 - 1.9400 - 52 Week Range
1.5600 - 10.9400 - Volume
43,639 - Avg. Volume
1,016,338 - Market Cap (intraday)
91.876M - Beta (5Y Monthly) -0.08
- PE Ratio (TTM)
-- - EPS (TTM)
-2.3100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.00
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
www.allurion.comRecent News: ALUR
Performance Overview: ALUR
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALUR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALUR
Valuation Measures
Market Cap
91.88M
Enterprise Value
95.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.28
Price/Book (mrq)
--
Enterprise Value/Revenue
1.79
Enterprise Value/EBITDA
-1.39
Financial Highlights
Profitability and Income Statement
Profit Margin
-150.76%
Return on Assets (ttm)
-80.31%
Return on Equity (ttm)
--
Revenue (ttm)
53.47M
Net Income Avi to Common (ttm)
-82.3M
Diluted EPS (ttm)
-2.3100
Balance Sheet and Cash Flow
Total Cash (mrq)
38.04M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-33.18M